Impact of Generics on the Antidepressant MarketDecision ResourcesDecember 5, 2005 13 Pages - SKU: DECR1212098 |
| The depression therapy market is one of the largest in the world. Several antidepressants have achieved blockbuster status. Although the market for antidepressants continues to grow, the rate of growth has slowed, in part because of generics competition. By 2010, the market-leading antidepressants will all face generics competition, at least in the United States. In this report, we examine the current antidepressant market and discuss the effect that increasing generics competition will have. Please note: the PDF e-mail from publisher version of this report is for a global site license. |
Related Markets
- Life Sciences
- Pharmaceuticals
- Pharmaceuticals
- Generics Drugs
- Prescription Drugs
- Therapeutic Area
- Behavioral Health
Behavioral Health Reports
- Key Companies: Depression - Leading players must adapt to remain competitive
- CNS Market Access in China - Investment in mental health services offers growth opportunities for psychiatry players
- Product Profiles: Depression - Next generation vies for second-line patients
- Alcohol Addiction Global Clinical Trials Review, Q2, 2011
- Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
